• About us
  • Membership
  • Contact us
  • Mon December 22, 2025

  • Home
  • Society
  • Economy
  • Politics
  • Sports
  • Culture
  • International
  • Multimedia
  • Tourism

Epidermolysis bullosa

Total:2

  • No lack of medical supplies for EB despite sanctions 2024-12-29 17:01

    No lack of medical supplies for EB despite sanctions

    TEHRAN –Despite sanctions, Iran’s Food and Drug Administration (IFDA) has managed to procure and store the essential medical supplies needed by Epidermolysis Bullosa (EB) patients, an official with IFDA has said.

  • Iran achieves technology to manufacture dressings for EB patients 2024-01-09 15:25

    Iran achieves technology to manufacture dressings for EB patients

    TEHRAN –An Iranian knowledge-based company has gained the technology for producing wound dressings for Epidermolysis Bullosa (EB) patients.

All Pages

Latest

  • Blood drips from their pens

  • Cinema Museum reviews Kiarostami’s “Fellow Citizen”

  • Iran, Tajikistan strengthen cultural ties

  • “Oscar Music Winners” film concert to be staged in Tehran

  • Iranian photographers honored in UNICEF’s 2025 Photo of the Year

  • Thailand FM slams ‘rushed’ Trump-brokered truce as fighting kills 40+

  • The Israeli campaign against UNRWA

  • ‘Totally unacceptable:’ Denmark to summon US ambassador over Trump’s Greenland appointment

  • Orban slams EU’s Ukraine policy: ‘Sanctions crushed Europe, not Russia’ 

  • A ceasefire that bleeds: Gaza war repackaged as peace

  • Lebanon’s phantom prince: A political scandal beyond ordinary fraud

  • The limits of pragmatism: Persistent fragility in US-PGCC ties 

  • Tajik travelers tour attractions in ancient Neyshabur

  • UNESCO-listed Tehran palace hosts exhibit of ebru arts

  • Dome of Shah Nematollah Vali Shrine restored

Desktop version Mobile version
Top
  • About us
  • Membership
  • Contact us
  • Home
  • Society
  • Economy
  • Politics
  • Sports
  • Culture
  • International
  • Multimedia
  • Tourism

All Content by Mehr News Agency is licensed under a Creative Commons Attribution 4.0 International License.

Developed by: Nastooh Designed by: Pixel Studio